Catalyst Pharmaceutical
CPRX
CPRX
268 hedge funds and large institutions have $1.53B invested in Catalyst Pharmaceutical in 2024 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 107 increasing their positions, 70 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.62% more ownership
Funds ownership: 81.06% → 81.68% (+0.62%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
16% less call options, than puts
Call options by funds: $1.78M | Put options by funds: $2.13M
Holders
268
Holding in Top 10
6
Calls
$1.78M
Puts
$2.13M
Top Buyers
| 1 | +$30.5M | |
| 2 | +$26.8M | |
| 3 | +$25.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$21.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.7M |
Top Sellers
| 1 | -$33.9M | |
| 2 | -$10.4M | |
| 3 | -$5.43M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
-$5.34M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$4.03M |